Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 303

1.

Seasonal influenza vaccine uptake and vaccine refusal among pregnant women in France: results from a national survey.

Descamps A, Launay O, Bonnet C, Blondel B.

Hum Vaccin Immunother. 2019 Nov 14:1-8. doi: 10.1080/21645515.2019.1688035. [Epub ahead of print]

PMID:
31725346
2.

Risks of non-vaccination.

Launay O.

Med Mal Infect. 2019 Oct 19. pii: S0399-077X(18)30851-5. doi: 10.1016/j.medmal.2019.09.016. [Epub ahead of print] No abstract available.

PMID:
31640882
3.

Alternative hepatitis B vaccine strategies in healthy non-responders to a first standard vaccination scheme.

Loubet P, Launay O.

Lancet Infect Dis. 2020 Jan;20(1):7-8. doi: 10.1016/S1473-3099(19)30582-1. Epub 2019 Oct 16. No abstract available.

PMID:
31629648
4.

Vaccination in adult liver transplantation candidates and recipients.

Valour F, Conrad A, Ader F, Launay O.

Clin Res Hepatol Gastroenterol. 2019 Oct 10. pii: S2210-7401(19)30191-3. doi: 10.1016/j.clinre.2019.08.007. [Epub ahead of print]

PMID:
31607643
5.

Attitudes, knowledge, and willingness to be vaccinated against seasonal influenza among patients hospitalized with Influenza-Like-Illness: impact of diagnostic testing.

Tubiana S, Launay O, Galtier F, Tattevin P, Postil D, Vanhems P, Lanzi N, Verger P, Duval X.

Hum Vaccin Immunother. 2019 Oct 7. doi: 10.1080/21645515.2019.1674598. [Epub ahead of print]

PMID:
31589554
6.

Barriers and motivations for participation in preventive vaccine clinical trials: Experience of 5 clinical research sites.

Detoc M, Launay O, Dualé C, Mutter C, Le Huec JC, Lenzi N, Lucht F, Gagneux-Brunon A, Botelho-Nevers E.

Vaccine. 2019 Oct 16;37(44):6633-6639. doi: 10.1016/j.vaccine.2019.09.048. Epub 2019 Sep 19.

PMID:
31543417
7.

Immunogenicity and Safety of 3 Formulations of a Respiratory Syncytial Virus Candidate Vaccine in Nonpregnant Women: A Phase 2, Randomized Trial.

Schwarz TF, McPhee RA, Launay O, Leroux-Roels G, Talli J, Picciolato M, Gao F, Cai R, Nguyen TL, Dieussaert I, Miller JM, Schmidt AC.

J Infect Dis. 2019 Oct 22;220(11):1816-1825. doi: 10.1093/infdis/jiz395.

8.

Does the availability of influenza vaccine at prenatal care visits and of immediate vaccination improve vaccination coverage of pregnant women?

Alessandrini V, Anselem O, Girault A, Mandelbrot L, Luton D, Launay O, Goffinet F.

PLoS One. 2019 Aug 1;14(8):e0220705. doi: 10.1371/journal.pone.0220705. eCollection 2019.

9.

The risk of a swine influenza pandemic: still a concern?

Loubet P, Enouf V, Launay O.

Expert Rev Respir Med. 2019 Sep;13(9):803-805. doi: 10.1080/17476348.2019.1645011. Epub 2019 Jul 24. No abstract available.

PMID:
31318298
10.

Long-term safety and vaccine-induced seropositivity in healthy volunteers from HIV vaccine trials.

Durier C, Desaint C, Lelièvre JD, Silbermann B, Pialoux G, Cuzin L, Bonnet B, Poizot-Martin I, Bouakane A, Paul C, Grabar S, Spire B, Meyer L, Launay O; ANRS/VRI COHVAC Study Group.

AIDS. 2019 Nov 1;33(13):2061-2071. doi: 10.1097/QAD.0000000000002310.

PMID:
31306171
11.

Vaccine Development: From Preclinical Studies to Phase 1/2 Clinical Trials.

Artaud C, Kara L, Launay O.

Methods Mol Biol. 2019;2013:165-176. doi: 10.1007/978-1-4939-9550-9_12.

PMID:
31267501
12.

HIV therapeutic vaccine enhances non-exhausted CD4+ T cells in a randomised phase 2 trial.

Vieillard V, Combadière B, Tubiana R, Launay O, Pialoux G, Cotte L, Girard PM, Simon A, Dudoit Y, Reynes J, Rockstroh J, Garcia F, Gatell J, Devidas A, Yazdanpanah Y, Weiss L, Fätkenheuer G, Autran B, Joyeux D, Gharakhanian S, Debré P, Katlama C.

NPJ Vaccines. 2019 Jun 3;4:25. doi: 10.1038/s41541-019-0117-5. eCollection 2019. Erratum in: NPJ Vaccines. 2019 Aug 13;4:36.

13.

Influenza epidemiology and influenza vaccine effectiveness during the 2015-2016 season: results from the Global Influenza Hospital Surveillance Network.

Puig-Barberà J, Mira-Iglesias A, Burtseva E, Cowling BJ, Serhat U, Ruiz-Palacios GM, Launay O, Kyncl J, Koul P, Siqueira MM, Sominina A; Global Influenza Hospital Surveillance Network.

BMC Infect Dis. 2019 May 14;19(1):415. doi: 10.1186/s12879-019-4017-0.

14.

Influenza vaccination of pregnant women in Paris, France: Knowledge, attitudes and practices among midwives.

Loubet P, Nguyen C, Burnet E, Launay O.

PLoS One. 2019 Apr 25;14(4):e0215251. doi: 10.1371/journal.pone.0215251. eCollection 2019.

15.

"Real life" use of raltegravir during pregnancy in France: The Coferal-IMEA048 cohort study.

Gantner P, Sylla B, Morand-Joubert L, Frange P, Lacombe K, Khuong MA, Duvivier C, Launay O, Karmochkine M, Arvieux C, Ménard A, Piroth L, Canestri A, Trias D, Peytavin G, Landman R, Ghosn J; Coferal-IMEA048 Study Group.

PLoS One. 2019 Apr 24;14(4):e0216010. doi: 10.1371/journal.pone.0216010. eCollection 2019.

16.

Booster Vaccination With GVGH Shigella sonnei 1790GAHB GMMA Vaccine Compared to Single Vaccination in Unvaccinated Healthy European Adults: Results From a Phase 1 Clinical Trial.

Launay O, Ndiaye AGW, Conti V, Loulergue P, Sciré AS, Landre AM, Ferruzzi P, Nedjaai N, Schütte LD, Auerbach J, Marchetti E, Saul A, Martin LB, Podda A.

Front Immunol. 2019 Mar 8;10:335. doi: 10.3389/fimmu.2019.00335. eCollection 2019.

17.

Innate gene signature distinguishes humoral versus cytotoxic responses to influenza vaccination.

Gonçalves E, Bonduelle O, Soria A, Loulergue P, Rousseau A, Cachanado M, Bonnabau H, Thiebaut R, Tchitchek N, Behillil S, van der Werf S, Vogt A, Simon T, Launay O, Combadière B.

J Clin Invest. 2019 Mar 7;129(5):1960-1971. doi: 10.1172/JCI125372. Print 2019 May 1.

18.

Corrigendum to 'A report on the status of vaccination in Europe' [Vaccine 36 (2018) 4979-4992].

Sheikh S, Biundo E, Courcier S, Damm O, Launay O, Maes E, Marcos C, Matthews S, Meijer C, Poscia A, Postma M, Saka O, Szucs T, Begg N.

Vaccine. 2019 Feb 28;37(10):1374-1376. doi: 10.1016/j.vaccine.2019.01.038. Epub 2019 Feb 4. No abstract available.

19.

How to improve vaccine acceptability (evaluation, pharmacovigilance, communication, public health, mandatory vaccination, fears and beliefs).

Dutilleul A, Morel J, Schilte C, Launay O; participants of Giens XXXIV Round Table “hot topic No. 1”.

Therapie. 2019 Feb;74(1):131-140. doi: 10.1016/j.therap.2018.12.005. Epub 2018 Dec 20.

PMID:
30660377
20.

Comment améliorer l’acceptabilité vaccinale (évaluation, pharmacovigilance, communication, santé publique, obligation vaccinale, peurs et croyances).

Dutilleul A, Morel J, Schilte C, Launay O; les participants à la table ronde « Sujet d’actualité (1) » des Ateliers de Giens XXXIV.

Therapie. 2019 Feb;74(1):119-129. doi: 10.1016/j.therap.2018.11.007. Epub 2018 Nov 27. French. No abstract available.

PMID:
30612731
21.

Bacillus Calmette-Guerin infection following intravesical instillation: Does the strain matter?

Levi LI, Schlemmer F, de Castro N, Brun O, Veziris N, Argemi X, Roupret M, Launay O, Bergeron A, Groh M; BCG infection study group.

Med Mal Infect. 2019 Aug;49(5):350-355. doi: 10.1016/j.medmal.2018.11.014. Epub 2018 Dec 21.

PMID:
30583869
22.

[History and principles of vaccination].

Canouï E, Launay O.

Rev Mal Respir. 2019 Jan;36(1):74-81. doi: 10.1016/j.rmr.2018.02.015. Epub 2018 Dec 20. Review. French.

PMID:
30579659
23.

Influence of geographic origin on AIDS and serious non-AIDS morbidity/mortality during cART among heterosexual HIV-infected men and women in France.

de Monteynard LA, Matheron S, Grabar S, de Truchis P, Gilquin J, Pavie J, Launay O, Meynard JL, Khuong-Josses MA, Rey D, Mahamat A, Dray-Spira R, Simon A, Costagliola D, Abgrall S; FHDH-ANRS CO4.

PLoS One. 2018 Oct 31;13(10):e0205385. doi: 10.1371/journal.pone.0205385. eCollection 2018.

24.

CD4+ cell count recovery after combined antiretroviral therapy in the modern combined antiretroviral therapy era.

Roul H, Mary-Krause M, Ghosn J, Delaugerre C, Pialoux G, Cuzin L, Launay O, Lacombe JM, Menard A, De Truchis P, Delfraissy JF, Weiss L, Costagliola D; FHDH-ANRS CO4.

AIDS. 2018 Nov 13;32(17):2605-2614. doi: 10.1097/QAD.0000000000002010.

PMID:
30289817
25.

Social and Behavioral Consequences of Participation in HIV Preventive Vaccine Trials in the ANRS COHVAC Cohort.

Durier C, Desaint C, Launay O.

J Acquir Immune Defic Syndr. 2018 Oct 1;79 Suppl 1:S37-S50. doi: 10.1097/QAI.0000000000001807.

PMID:
30222704
26.

[Quadrivalent influenza vaccine: What is changed and what are the benefits?]

Mosnier A, Launay O, Martinez L, Gavazzi G, Josset L, Crepey P, Hannoun C, Weil-Olivier C, Gaillat J.

Presse Med. 2018 Oct;47(10):842-853. doi: 10.1016/j.lpm.2018.06.013. Epub 2018 Sep 13. French.

27.

Conjugate Haemophilus influenzae type b vaccines for sickle cell disease.

Allali S, Chalumeau M, Launay O, Ballas SK, de Montalembert M.

Cochrane Database Syst Rev. 2018 Aug 20;8:CD011199. doi: 10.1002/14651858.CD011199.pub3.

28.

Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients.

Colin de Verdiere N, Durier C, Samri A, Meiffredy V, Launay O, Matheron S, Mercier-Delarue S, Even S, Aboulker JP, Molina JM, Autran B, Simon F; ANRS EP46 NOVAA Group.

AIDS. 2018 Oct 23;32(16):2291-2299. doi: 10.1097/QAD.0000000000001963.

PMID:
30096071
29.

Reply to the comment of Fayet et al. Obstacles and motivations to influenza and pneumococcal vaccination in patients with rheumatoid arthritis. A qualitative study.

Assala M, Groh M, Blanche P, Vinter C, Cohen P, Le Guern V, Puéchal X, Mouthon L, Le Jeunne C, Launay O, Kernéis S.

Joint Bone Spine. 2019 Jan;86(1):119. doi: 10.1016/j.jbspin.2018.06.015. Epub 2018 Jul 24. No abstract available.

PMID:
30053610
30.

A report on the status of vaccination in Europe.

Sheikh S, Biundo E, Courcier S, Damm O, Launay O, Maes E, Marcos C, Matthews S, Meijer C, Poscia A, Postma M, Saka O, Szucs T, Begg N.

Vaccine. 2018 Aug 9;36(33):4979-4992. doi: 10.1016/j.vaccine.2018.06.044. Epub 2018 Jul 4. Review. Erratum in: Vaccine. 2019 Feb 28;37(10):1374-1376.

31.

[How to minimize the risk of infection in systemic lupus erythematosus?]

Costedoat-Chalumeau N, Groh M, Piette JC, Launay O.

Rev Med Interne. 2019 Jun;40(6):347-350. doi: 10.1016/j.revmed.2018.06.002. Epub 2018 Jun 22. French. No abstract available.

PMID:
29937299
32.

Immunization during pregnancy.

Loubet P, Anselem O, Launay O.

Expert Rev Vaccines. 2018 May;17(5):383-393. doi: 10.1080/14760584.2018.1471988. Epub 2018 May 9. Review.

PMID:
29715051
33.

Vaccines for healthcare-associated infections: present, future, and expectations.

Gagneux-Brunon A, Lucht F, Launay O, Berthelot P, Botelho-Nevers E.

Expert Rev Vaccines. 2018 May;17(5):421-433. doi: 10.1080/14760584.2018.1470507. Epub 2018 May 7. Review.

PMID:
29697286
34.

Immunogenicity and persistence of a prime-boost re-vaccination strategy for pneumococcal vaccines in patients with rheumatoid arthritis.

Bahuaud M, Beaudouin-Bazire C, Husson M, Molto A, Launay O, Batteux F, Dougados M.

Hum Vaccin Immunother. 2018 Jun 3;14(6):1464-1470. doi: 10.1080/21645515.2018.1438091. Epub 2018 Apr 9.

35.

Cost-effectiveness of vaccination against cytomegalovirus (CMV) in adolescent girls to prevent infections in pregnant women living in France.

N'Diaye DS, Launay O, Picone O, Tsatsaris V, Azria E, Rozenberg F, Schwarzinger M, Yazdanpanah Y.

Vaccine. 2018 Feb 28;36(10):1285-1296. doi: 10.1016/j.vaccine.2018.01.042. Epub 2018 Feb 1.

PMID:
29397227
36.

Pneumococcal and influenza vaccine uptake in adults with inflammatory bowel disease in France: Results from a web-based study.

Loubet P, Verger P, Abitbol V, Peyrin-Biroulet L, Launay O.

Dig Liver Dis. 2018 Jun;50(6):563-567. doi: 10.1016/j.dld.2017.12.027. Epub 2018 Jan 2.

PMID:
29371056
37.

Immunogenicity and persistence of the 13-valent Pneumococcal Conjugate Vaccine (PCV13) in patients with untreated Smoldering Multiple Myeloma (SMM): A pilot study.

Bahuaud M, Bodilis H, Malphettes M, Maugard Landre A, Matondo C, Bouscary D, Batteux F, Launay O, Fermand JP.

Heliyon. 2017 Nov 6;3(11):e00441. doi: 10.1016/j.heliyon.2017.e00441. eCollection 2017 Nov.

38.

Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 season.

Rondy M, Gherasim A, Casado I, Launay O, Rizzo C, Pitigoi D, Mickiene A, Marbus SD, Machado A, Syrjänen RK, Pem-Novose I, Horváth JK, Larrauri A, Castilla J, Vanhems P, Alfonsi V, Ivanciuc AE, Kuliese M, van Gageldonk-Lafeber R, Gomez V, Ikonen N, Lovric Z, Ferenczi A, Moren A; I-MOVE+ hospital working group.

Euro Surveill. 2017 Oct;22(41). doi: 10.2807/1560-7917.ES.2017.22.41.17-00645.

39.

Patients With Isolated Hepatitis B Core Antibody: Has the Time Come to Vaccinate?

Piroth L, Launay O, Miailhes P, Carrat F, Rey D.

Clin Infect Dis. 2018 Jan 6;66(2):317-318. doi: 10.1093/cid/cix822. No abstract available.

PMID:
29020394
40.

Impact of Sequential Culture Results on Diagnosis and De-Escalation of the Antibiotic Regimen in Joint and Bone Infections.

Kernéis S, Leprince C, Archambeau D, Eyrolle L, Leclerc P, Poupet H, Loubinoux J, Gauzit R, Salmon D, Launay O, Poyart C, Anract P, Morand PC.

Surg Infect (Larchmt). 2017 Nov/Dec;18(8):910-914. doi: 10.1089/sur.2017.106. Epub 2017 Oct 3.

PMID:
28972874
41.

Penetration and antiviral efficacy of total and unbound maraviroc, raltegravir and rilpivirine in both female and male genital fluids from HIV-positive patients receiving regimens containing these antiretrovirals.

Lê MP, Belarbi L, Chaix ML, Dulioust E, Mahjoub N, Salmon D, Viard JP, Duvivier C, Peytavin G, Launay O, Ghosn J.

J Antimicrob Chemother. 2017 Nov 1;72(11):3167-3171. doi: 10.1093/jac/dkx275.

PMID:
28961979
42.

The value of molecular techniques to diagnose Ureaplasma urealyticum and Nocardia farcinica pleuropneumonia in a patient with diffuse large B-cell lymphoma.

Canouï E, Blanc K, Loubinoux J, Valade S, Hamard C, Lefebvre A, Amorim S, Bébéar C, Rodriguez-Nava V, Lebeaux D, Launay O, Alifano M, Rabbat A, Kernéis S.

Int J Infect Dis. 2017 Nov;64:93-95. doi: 10.1016/j.ijid.2017.09.015. Epub 2017 Sep 22.

43.

Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1-DiCo malaria vaccine adjuvanted with GLA-SE or Alhydrogel® in European and African adults: A phase 1a/1b, randomized, double-blind multi-centre trial.

Sirima SB, Durier C, Kara L, Houard S, Gansane A, Loulergue P, Bahuaud M, Benhamouda N, Nebié I, Faber B, Remarque E, Launay O; AMA1-DiCo Study Group.

Vaccine. 2017 Oct 27;35(45):6218-6227. doi: 10.1016/j.vaccine.2017.09.027. Epub 2017 Sep 22.

PMID:
28947345
44.

Effectiveness of seasonal influenza vaccination in patients with diabetes: protocol for a nested case-control study.

Casanova L, Cortaredona S, Gaudart J, Launay O, Vanhems P, Villani P, Verger P.

BMJ Open. 2017 Aug 18;7(8):e016023. doi: 10.1136/bmjopen-2017-016023.

45.

2015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1)pdm09 and B among elderly people in Europe: results from the I-MOVE+ project.

Rondy M, Larrauri A, Casado I, Alfonsi V, Pitigoi D, Launay O, Syrjänen RK, Gefenaite G, Machado A, Vučina VV, Horváth JK, Paradowska-Stankiewicz I, Marbus SD, Gherasim A, Díaz-González JA, Rizzo C, Ivanciuc AE, Galtier F, Ikonen N, Mickiene A, Gomez V, Kurečić Filipović S, Ferenczi A, Korcinska MR, van Gageldonk-Lafeber R; I-MOVE+ hospital working group, Valenciano M.

Euro Surveill. 2017 Jul 27;22(30). pii: 30580. doi: 10.2807/1560-7917.ES.2017.22.30.30580.

46.

Pneumococcal vaccination in patients with systemic lupus erythematosus: A multicenter placebo-controlled randomized double-blind study.

Grabar S, Groh M, Bahuaud M, Le Guern V, Costedoat-Chalumeau N, Mathian A, Hanslik T, Guillevin L, Batteux F, Launay O; VACCILUP study group.

Vaccine. 2017 Sep 5;35(37):4877-4885. doi: 10.1016/j.vaccine.2017.07.094. Epub 2017 Aug 4.

PMID:
28784280
47.

Prognostic Factors in Syphilitic Uveitis.

Hoogewoud F, Frumholtz L, Loubet P, Charlier C, Blanche P, Lebeaux D, Benhaddou N, Sedira N, Coutte L, Vanhaecke C, Launay O, Le Jeunne C, Héron E, Monnet D, Lortholary O, Sahel JA, Dupin N, Brézin A, Errera MH, Salah S, Groh M.

Ophthalmology. 2017 Dec;124(12):1808-1816. doi: 10.1016/j.ophtha.2017.06.003. Epub 2017 Aug 2.

PMID:
28779905
48.

Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in Europe.

Launay O, Lewis DJM, Anemona A, Loulergue P, Leahy J, Sciré AS, Maugard A, Marchetti E, Zancan S, Huo Z, Rondini S, Marhaba R, Finco O, Martin LB, Auerbach J, Cohen D, Saul A, Gerke C, Podda A.

EBioMedicine. 2017 Aug;22:164-172. doi: 10.1016/j.ebiom.2017.07.013. Epub 2017 Jul 15.

49.

Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza.

Rondy M, Launay O, Castilla J, Costanzo S, Puig-Barberà J, Gefenaite G, Larrauri A, Rizzo C, Pitigoi D, Syrjänen RK, Machado A, Kurečić Filipović S, Krisztina Horváth J, Paradowska-Stankiewicz I, Marbus S; InNHOVE/I-MOVE+working group, Moren A.

Vaccine. 2017 Aug 3;35(34):4298-4306. doi: 10.1016/j.vaccine.2017.06.088. Epub 2017 Jul 11.

50.

Maternal influenza immunisation to reduce influenza infections and low birthweight in infants in resource-limited countries.

Loubet P, Launay O.

Lancet Infect Dis. 2017 Sep;17(9):890-892. doi: 10.1016/S1473-3099(17)30250-5. Epub 2017 May 15. No abstract available.

PMID:
28522337

Supplemental Content

Loading ...
Support Center